BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 19077110)

  • 1. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of minocycline on inflammation-induced damage to the blood-brain barrier and white matter during development.
    Stolp HB; Ek CJ; Johansson PA; Dziegielewska KM; Potter AM; Habgood MD; Saunders NR
    Eur J Neurosci; 2007 Dec; 26(12):3465-74. PubMed ID: 18088277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors involved in inflammation-induced developmental white matter damage.
    Stolp HB; Ek CJ; Johansson PA; Dziegielewska KM; Bethge N; Wheaton BJ; Potter AM; Saunders NR
    Neurosci Lett; 2009 Feb; 451(3):232-6. PubMed ID: 19152829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blood-brain barrier in health and chronic neurodegenerative disorders.
    Zlokovic BV
    Neuron; 2008 Jan; 57(2):178-201. PubMed ID: 18215617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide and neurological disorders.
    Duncan AJ; Heales SJ
    Mol Aspects Med; 2005; 26(1-2):67-96. PubMed ID: 15722115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does acidosis in brain play a role in Alzheimer's disease?].
    Pirchl M; Humpel C
    Neuropsychiatr; 2009; 23(3):187-92. PubMed ID: 19703385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat.
    Stolp HB; Dziegielewska KM; Ek CJ; Potter AM; Saunders NR
    Eur J Neurosci; 2005 Dec; 22(11):2805-16. PubMed ID: 16324115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown.
    Levin EC; Acharya NK; Han M; Zavareh SB; Sedeyn JC; Venkataraman V; Nagele RG
    Brain Res; 2010 Jul; 1345():221-32. PubMed ID: 20546711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakdown of the blood-brain barrier to proteins in white matter of the developing brain following systemic inflammation.
    Stolp HB; Dziegielewska KM; Ek CJ; Habgood MD; Lane MA; Potter AM; Saunders NR
    Cell Tissue Res; 2005 Jun; 320(3):369-78. PubMed ID: 15846513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sense of smell, physiological ageing and neurodegenerative diseases: II. Ageing and neurodegenerative diseases].
    Fusari A; Molina JA
    Rev Neurol; 2009 Oct 1-15; 49(7):363-9. PubMed ID: 19774531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: relationship to S-100B levels and blood-brain barrier function.
    Gressner OA; Schifflers MC; Kim P; Heuts L; Lahme B; Gressner AM
    Clin Chim Acta; 2009 Feb; 400(1-2):86-90. PubMed ID: 19000909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation in the nervous system--physiological and pathophysiological aspects.
    Schultzberg M; Lindberg C; Aronsson AF; Hjorth E; Spulber SD; Oprica M
    Physiol Behav; 2007 Sep; 92(1-2):121-8. PubMed ID: 17597167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cerebrovascular aging].
    Buée L
    Therapie; 1999; 54(1):155-65. PubMed ID: 10216439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maillard reaction versus other nonenzymatic modifications in neurodegenerative processes.
    Pamplona R; Ilieva E; Ayala V; Bellmunt MJ; Cacabelos D; Dalfo E; Ferrer I; Portero-Otin M
    Ann N Y Acad Sci; 2008 Apr; 1126():315-9. PubMed ID: 18079479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of protein nitration in brain injury: a key pathophysiological mechanism in neurodegenerative, autoimmune, or inflammatory CNS diseases and stroke.
    Sarchielli P; Galli F; Floridi A; Floridi A; Gallai V
    Amino Acids; 2003 Dec; 25(3-4):427-36. PubMed ID: 14661102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier alterations in ageing and dementia.
    Popescu BO; Toescu EC; Popescu LM; Bajenaru O; Muresanu DF; Schultzberg M; Bogdanovic N
    J Neurol Sci; 2009 Aug; 283(1-2):99-106. PubMed ID: 19264328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schizophrenia--neurodevelopmental and neurodegenerative theory revisited].
    Szulc A; Galińska B; Czernikiewicz A
    Psychiatr Pol; 2005; 39(2):249-58. PubMed ID: 15881620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive aspects of estrogen].
    Ciesielska A
    Neurol Neurochir Pol; 2003; 37 Suppl 3():79-92. PubMed ID: 14560702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and autoimmunity as a central theme in neurodegenerative disorders: fact or fiction?
    Clarkson AN; Rahman R; Appleton I
    Curr Opin Investig Drugs; 2004 Jul; 5(7):706-13. PubMed ID: 15298065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Schizophrenia: neurodevelopmental disorder or degenerative brain process?].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S57-62. PubMed ID: 18461546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.